Metrics to compare | 6748 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6748PeersSector | |
|---|---|---|---|---|
P/E Ratio | −191.5x | −4.2x | −0.2x | |
PEG Ratio | −21.80 | 0.03 | 0.00 | |
Price / Book | 14.2x | 1.5x | 2.6x | |
Price / LTM Sales | 286.0x | 30.9x | 2.6x | |
Upside (Analyst Target) | - | 0.0% | 76.9% | |
Fair Value Upside | Unlock | 7.7% | 14.9% | Unlock |
ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally. The company engages in manufacturing medical devices and cosmetics; research, design, production, and sales of biological tissue implants; and dental and orthopedic implants, collagen, and related derivative products. It also offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. ACRO Biomedical Co., Ltd. was founded in 2014 and is based in Kaohsiung, Taiwan.